Browsing Category
Disruptive Pharma
Positive Preclinical Results Unveiled for DPH001
August 23, 2023, Disruptive Pharma Announcement by Peter Åsberg
We're delighted to share positive results from our recent preclinical study for DPH001. With our innovative MMC technology, researchers at Disruptive Pharma AB have engineered an improved sorafenib formulation intended for the…
Read More...
Read More...